These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22635238)

  • 1. Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy.
    Montaruli B; De Luna E; Mengozzi G; Molinari F; Napolitano E; Napoli P; Nicolo C; Romito A; Stella S; Bazzan M; Bertero MT; Carignola R; Marchese C
    Lupus; 2012 Jun; 21(7):799-801. PubMed ID: 22635238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies.
    Montaruli B; De Luna E; Erroi L; Marchese C; Mengozzi G; Napoli P; Nicolo' C; Romito A; Bertero MT; Sivera P; Migliardi M
    Int J Lab Hematol; 2016 Apr; 38(2):172-82. PubMed ID: 26847159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines.
    Bor MV; Jacobsen IS; Gram JB; Sidelmann JJ
    Lupus; 2018 Aug; 27(9):1446-1454. PubMed ID: 29848159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
    Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Van Hoecke F; Persijn L; Decavele AS; Devreese K
    Int J Lab Hematol; 2012 Dec; 34(6):630-40. PubMed ID: 22827598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-β2-glycoprotein I antibodies are highly prevalent in a large number of Brazilian leprosy patients.
    Ribeiro SL; Pereira HL; Silva NP; Souza AW; Sato EI
    Acta Reumatol Port; 2011; 36(1):30-7. PubMed ID: 21483278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
    Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
    Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Decavele AS; Schouwers S; Devreese KM
    Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of new commercial enzyme-linked immunosorbent assay kits in the laboratory diagnosis of antiphospholipid syndrome in view of the revised classification criteria of the antiphospholipid syndrome.
    Devreese KM
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):651-9. PubMed ID: 17102652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.